Additional in vitro studies are needed to clarify the effects of GRP94 inhibition on the crosstalk between macrophages and other cells in the tumor microenvironment, such as cytotoxic T cells, regulatory T cells, and cancer-associated fibroblasts. Here, HSP90B1 is linked to neoplasm.